Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy

· Biocells Medical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis [EARLY_Phase 1]

See pricing